Dr Rajiv Karbhal

Dr Karbhal started his journey after his phD in Germany at the Institute of Environmental Medicine in Augsburg. His role as a Bioinformatics and IT officer helped him develop both professional skill and interest in AI and digital health.

Neha Periwal PhD.

Researcher at Vgenomics. During her time at Jamia Hamdard, she gained exposure in both applying machine learning as well as deep learning techniques which can be applied to parse datasets in multiple omics fields.

Abhinav Kaushik PhD.

Our US based scientific advisor is currently a Researcher at Harvard University with the T.H. Chan School of Public Health. He has done extensive research into T cell immunity and provides valuable insight to the team.

Abdul Khalique PhD.

Our scientific advisor based in the US is currently a research scientist at MD Anderson Cancer Center. Previously at NIH, as a professor, he accumulated over a decade of research experience including the field of rare diseases.

Preeti Gupta Lal PhD.

Chief Scientific Officer (CSO). She has 150 plus patents and boasts 30+ years of research experience in translational medicine, data science and clinical biomarker implementation.

Rahila Sardar PhD.

Founder and CEO of Vgenomics. Notably, she was among the first researchers to publish a paper on COVID-19 in India, underscoring her commitment to addressing pressing global health concerns.

With a decade of diverse experience under his belt, Sameer Malik, an alumnus of the Delhi School of Economics, brings a robust blend of business strategy, finance, operations, and sales expertise to Vgenomics. From kick starting his career at KPMG to founding and scaling an e-commerce startup to over $1.5 million in annual revenues, and further contributing to the startup ecosystem through his involvement in Startup Nexus and Token Amigo, Sameer has navigated through various industries, consistently playing to his strategic and operational strengths. His rich entrepreneurial journey and strategic acumen are now channeled towards advancing Vgenomics' mission in the realm of rare inborn diseases diagnostics and therapeutic solutions.

A translational biologist based in Silicon Valley, Dr. Lal brings her expertise in data science, translational medicine, clinical biomarker, and CDx implementation across all phases of clinical trials development to Vgenomics. With over 150 patents to her name, she has substantial experience in regulatory interactions with both the drug and device divisions of the FDA, and companion diagnostics (Dx) programs.

After earning her doctorate from International Center of Genetic Engineering and Biotechnology (ICGEB), Dr. Sardar embarked on a mission to transform her research findings into practical applications that could benefit rare disease patients globally. She noticed a gap in dedicated solutions for the burgeoning hub of rare diseases in India, particularly those affecting children, and co-founded Vgenomics with Dr. Preeti to develop affordable diagnostics and therapeutic solutions.

Open chat
✉ Hey! Need Help?
Can we help you?